All Japan articles
-
BusinessMitsubishi Tanabe Pharma buys Neuroderm for $1.1 billion
Japanese pharmaceutical giant to acquire Israel’s Neuroderm in record breaking deal
-
News
China blamed for mercury on iconic Mount Fuji
Pollution research adds to simmering row between Japan and China over disputed islands
-
News
Fukushima disaster has not raised cancer risks, says UN
Latest study at odds with others that predicted a slight increase in certain types of tumours
-
News
Fukushima disaster predicted to raise cancer rates slightly
World Health Organization report expects cancer risk to rise marginally, but doesn’t put a figure on the number of deaths expected
-
News
Rebuilding public trust in Japanese science
Public faith in the role of science-based decision-making faltered after the tsunami and Fukushima and won’t be easy recover
-
News
Methane hydrate success
The US and Japan have successfully completed their trial of methane hydrate production technologies
-
News
Quake-hit Japanese universities move on
Among the universities damaged by the earthquake, by far the hardest hit was Tohoku University
